Bella Ungar

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases

Bella Ungar, Idan Levy, Yarden Yavne et al. · Clinical Gastroenterology and Hepatology · 2015 · 360 citations

Inflammation, Rheumatology, Mucosal Healing +12

Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab

Henit Yanai, Lev Lichtenstein, Amit Assa et al. · Clinical Gastroenterology and Hepatology · 2014 · 306 citations

Anti-inflammatory, Autoimmune Disease, Immunology +6

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Bella Ungar, Yehuda Chowers, Miri Yavzori et al. · Gut · 2013 · 298 citations

Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima

Shomron Ben‐Horin, Miri Yavzori, Itai Benhar et al. · Gut · 2015 · 174 citations

Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn’s Disease

Yana Davidov, Bella Ungar, Haggai Bar‐Yoseph et al. · Journal of Crohn s and Colitis · 2016 · 134 citations · Full text